fyi is reporting that president trump is believed to be referring to the proposal discussed in october that wo
@pharmajoya @StephArmour1FYI @StephArmour1is reporting that President Trump is believed to be referring to the proposal, discussed in October, that would test indexing the prices paid for select drugs:
pharma and biotech shares fall on president trump s remarks that an executive order is coming that would limit
Pharma and biotech shares fall on PresidentTrump's remarks that an executive order is coming that would limit how much the U.S. federal government pays for drugs to the lowest price paid elsewhere in the world. @StephArmour1 reports:
a new multiple myeloma treatment receives approval from xpovio from kpti is for use with dexamethasone in adul
A new multiple myeloma treatment receives approval from @US_FDA. Xpovio, from $KPTI, is for use with dexamethasone in adults who have relapsed refractory multiple myeloma and got at least four therapies previously.
less than 5 of kindergartners in california werent fully vaccinated in 2017 down from 98 four years earlier ac
Less than 5% of kindergartners in California weren’t fully vaccinated in 2017, down from 9.8% four years earlier, according to a new study, which shows the impact of tighter vaccine requirements and education, @Brabbott42 reports
tech platforms are tweaking their algorithms and cutting off advertising for pages and videos promoting scient
Tech platforms are tweaking their algorithms and cutting off advertising for pages and videos promoting scientifically dubious and potentially harmful information about cancer treatment, @danielas_bot and @bobmcmillan report
doctors are giving shock therapy a second look because it can be effective for patients with severe symptoms a
Doctors are giving shock therapy a second look, because it can be effective for patients with severe symptoms and is safer than previously, @rddysum writes Earlier this year, @US_FDA reclassified as moderate risk, from high.
so far this year pharma companies have taken 3653 price increases on 1045 different drug products according to
So far this year, pharma companies have taken 3,653 price increases on 1,045 different drug products, according to Raymond James & Associates. Among them: a spray Ambien whose price was just increased by as much as 843%